nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—CYP3A4—bone cancer	0.3	1	CbGaD
Valproic Acid—UGT2B7—Epirubicin—bone cancer	0.114	0.283	CbGbCtD
Valproic Acid—SLC16A1—Methotrexate—bone cancer	0.108	0.268	CbGbCtD
Valproic Acid—SLC22A7—Methotrexate—bone cancer	0.0532	0.132	CbGbCtD
Valproic Acid—SLC22A8—Methotrexate—bone cancer	0.0325	0.0805	CbGbCtD
Valproic Acid—CYP2B6—Cisplatin—bone cancer	0.0303	0.075	CbGbCtD
Valproic Acid—SLC22A6—Methotrexate—bone cancer	0.0226	0.0561	CbGbCtD
Valproic Acid—CYP2B6—Doxorubicin—bone cancer	0.0203	0.0503	CbGbCtD
Valproic Acid—CYP2C9—Cisplatin—bone cancer	0.016	0.0396	CbGbCtD
Valproic Acid—CYP3A4—Doxorubicin—bone cancer	0.00623	0.0154	CbGbCtD
Valproic Acid—Urinary tract disorder—Methotrexate—bone cancer	0.000177	0.00105	CcSEcCtD
Valproic Acid—Photosensitivity reaction—Doxorubicin—bone cancer	0.000177	0.00105	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Epirubicin—bone cancer	0.000176	0.00104	CcSEcCtD
Valproic Acid—Weight increased—Doxorubicin—bone cancer	0.000176	0.00104	CcSEcCtD
Valproic Acid—Epistaxis—Epirubicin—bone cancer	0.000176	0.00104	CcSEcCtD
Valproic Acid—Urethral disorder—Methotrexate—bone cancer	0.000175	0.00104	CcSEcCtD
Valproic Acid—Weight decreased—Doxorubicin—bone cancer	0.000175	0.00104	CcSEcCtD
Valproic Acid—Sinusitis—Epirubicin—bone cancer	0.000175	0.00104	CcSEcCtD
Valproic Acid—Agranulocytosis—Epirubicin—bone cancer	0.000174	0.00103	CcSEcCtD
Valproic Acid—Pneumonia—Doxorubicin—bone cancer	0.000174	0.00103	CcSEcCtD
Valproic Acid—Drowsiness—Doxorubicin—bone cancer	0.000173	0.00102	CcSEcCtD
Valproic Acid—Visual impairment—Methotrexate—bone cancer	0.000172	0.00102	CcSEcCtD
Valproic Acid—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000171	0.00101	CcSEcCtD
Valproic Acid—Hypersensitivity—Cisplatin—bone cancer	0.000171	0.00101	CcSEcCtD
Valproic Acid—Bradycardia—Epirubicin—bone cancer	0.000171	0.00101	CcSEcCtD
Valproic Acid—Erythema multiforme—Methotrexate—bone cancer	0.000169	0.001	CcSEcCtD
Valproic Acid—Haemoglobin—Epirubicin—bone cancer	0.000168	0.000996	CcSEcCtD
Valproic Acid—Stomatitis—Doxorubicin—bone cancer	0.000168	0.000996	CcSEcCtD
Valproic Acid—Rhinitis—Epirubicin—bone cancer	0.000168	0.000994	CcSEcCtD
Valproic Acid—Urinary tract infection—Doxorubicin—bone cancer	0.000168	0.000993	CcSEcCtD
Valproic Acid—Conjunctivitis—Doxorubicin—bone cancer	0.000168	0.000993	CcSEcCtD
Valproic Acid—Haemorrhage—Epirubicin—bone cancer	0.000167	0.000991	CcSEcCtD
Valproic Acid—Eye disorder—Methotrexate—bone cancer	0.000167	0.00099	CcSEcCtD
Valproic Acid—Tinnitus—Methotrexate—bone cancer	0.000167	0.000987	CcSEcCtD
Valproic Acid—Hypoaesthesia—Epirubicin—bone cancer	0.000167	0.000986	CcSEcCtD
Valproic Acid—Asthenia—Cisplatin—bone cancer	0.000166	0.000984	CcSEcCtD
Valproic Acid—Pharyngitis—Epirubicin—bone cancer	0.000166	0.000984	CcSEcCtD
Valproic Acid—Sweating—Doxorubicin—bone cancer	0.000166	0.000979	CcSEcCtD
Valproic Acid—Urinary tract disorder—Epirubicin—bone cancer	0.000165	0.000979	CcSEcCtD
Valproic Acid—Oedema peripheral—Epirubicin—bone cancer	0.000165	0.000976	CcSEcCtD
Valproic Acid—Connective tissue disorder—Epirubicin—bone cancer	0.000165	0.000974	CcSEcCtD
Valproic Acid—Urethral disorder—Epirubicin—bone cancer	0.000164	0.000971	CcSEcCtD
Valproic Acid—Hepatobiliary disease—Doxorubicin—bone cancer	0.000163	0.000966	CcSEcCtD
Valproic Acid—Epistaxis—Doxorubicin—bone cancer	0.000163	0.000963	CcSEcCtD
Valproic Acid—Angiopathy—Methotrexate—bone cancer	0.000162	0.000961	CcSEcCtD
Valproic Acid—Sinusitis—Doxorubicin—bone cancer	0.000162	0.000958	CcSEcCtD
Valproic Acid—Immune system disorder—Methotrexate—bone cancer	0.000162	0.000956	CcSEcCtD
Valproic Acid—Visual impairment—Epirubicin—bone cancer	0.000161	0.000955	CcSEcCtD
Valproic Acid—Mediastinal disorder—Methotrexate—bone cancer	0.000161	0.000954	CcSEcCtD
Valproic Acid—Agranulocytosis—Doxorubicin—bone cancer	0.000161	0.000953	CcSEcCtD
Valproic Acid—Chills—Methotrexate—bone cancer	0.000161	0.00095	CcSEcCtD
Valproic Acid—Diarrhoea—Cisplatin—bone cancer	0.000159	0.000938	CcSEcCtD
Valproic Acid—Erythema multiforme—Epirubicin—bone cancer	0.000158	0.000937	CcSEcCtD
Valproic Acid—Alopecia—Methotrexate—bone cancer	0.000158	0.000936	CcSEcCtD
Valproic Acid—Bradycardia—Doxorubicin—bone cancer	0.000158	0.000933	CcSEcCtD
Valproic Acid—Mental disorder—Methotrexate—bone cancer	0.000157	0.000928	CcSEcCtD
Valproic Acid—Eye disorder—Epirubicin—bone cancer	0.000157	0.000926	CcSEcCtD
Valproic Acid—Tinnitus—Epirubicin—bone cancer	0.000156	0.000924	CcSEcCtD
Valproic Acid—Malnutrition—Methotrexate—bone cancer	0.000156	0.000922	CcSEcCtD
Valproic Acid—Haemoglobin—Doxorubicin—bone cancer	0.000156	0.000922	CcSEcCtD
Valproic Acid—Rhinitis—Doxorubicin—bone cancer	0.000155	0.000919	CcSEcCtD
Valproic Acid—Haemorrhage—Doxorubicin—bone cancer	0.000155	0.000917	CcSEcCtD
Valproic Acid—Hypoaesthesia—Doxorubicin—bone cancer	0.000154	0.000912	CcSEcCtD
Valproic Acid—Pharyngitis—Doxorubicin—bone cancer	0.000154	0.00091	CcSEcCtD
Valproic Acid—Urinary tract disorder—Doxorubicin—bone cancer	0.000153	0.000906	CcSEcCtD
Valproic Acid—Oedema peripheral—Doxorubicin—bone cancer	0.000153	0.000903	CcSEcCtD
Valproic Acid—Dysgeusia—Methotrexate—bone cancer	0.000153	0.000903	CcSEcCtD
Valproic Acid—Connective tissue disorder—Doxorubicin—bone cancer	0.000152	0.000901	CcSEcCtD
Valproic Acid—Angiopathy—Epirubicin—bone cancer	0.000152	0.000899	CcSEcCtD
Valproic Acid—Urethral disorder—Doxorubicin—bone cancer	0.000152	0.000899	CcSEcCtD
Valproic Acid—Immune system disorder—Epirubicin—bone cancer	0.000151	0.000895	CcSEcCtD
Valproic Acid—Mediastinal disorder—Epirubicin—bone cancer	0.000151	0.000893	CcSEcCtD
Valproic Acid—Back pain—Methotrexate—bone cancer	0.000151	0.000892	CcSEcCtD
Valproic Acid—Chills—Epirubicin—bone cancer	0.00015	0.000889	CcSEcCtD
Valproic Acid—Arrhythmia—Epirubicin—bone cancer	0.00015	0.000885	CcSEcCtD
Valproic Acid—Visual impairment—Doxorubicin—bone cancer	0.000149	0.000884	CcSEcCtD
Valproic Acid—Alopecia—Epirubicin—bone cancer	0.000148	0.000876	CcSEcCtD
Valproic Acid—Vomiting—Cisplatin—bone cancer	0.000147	0.000872	CcSEcCtD
Valproic Acid—Vision blurred—Methotrexate—bone cancer	0.000147	0.000869	CcSEcCtD
Valproic Acid—Mental disorder—Epirubicin—bone cancer	0.000147	0.000868	CcSEcCtD
Valproic Acid—Erythema multiforme—Doxorubicin—bone cancer	0.000147	0.000867	CcSEcCtD
Valproic Acid—Rash—Cisplatin—bone cancer	0.000146	0.000864	CcSEcCtD
Valproic Acid—Dermatitis—Cisplatin—bone cancer	0.000146	0.000864	CcSEcCtD
Valproic Acid—Malnutrition—Epirubicin—bone cancer	0.000146	0.000863	CcSEcCtD
Valproic Acid—Eye disorder—Doxorubicin—bone cancer	0.000145	0.000857	CcSEcCtD
Valproic Acid—Ill-defined disorder—Methotrexate—bone cancer	0.000145	0.000855	CcSEcCtD
Valproic Acid—Tinnitus—Doxorubicin—bone cancer	0.000144	0.000855	CcSEcCtD
Valproic Acid—Anaemia—Methotrexate—bone cancer	0.000144	0.000852	CcSEcCtD
Valproic Acid—Flatulence—Epirubicin—bone cancer	0.000144	0.00085	CcSEcCtD
Valproic Acid—Tension—Epirubicin—bone cancer	0.000143	0.000847	CcSEcCtD
Valproic Acid—Dysgeusia—Epirubicin—bone cancer	0.000143	0.000845	CcSEcCtD
Valproic Acid—Nervousness—Epirubicin—bone cancer	0.000142	0.000838	CcSEcCtD
Valproic Acid—Back pain—Epirubicin—bone cancer	0.000141	0.000834	CcSEcCtD
Valproic Acid—Angiopathy—Doxorubicin—bone cancer	0.000141	0.000832	CcSEcCtD
Valproic Acid—Malaise—Methotrexate—bone cancer	0.000141	0.000831	CcSEcCtD
Valproic Acid—Muscle spasms—Epirubicin—bone cancer	0.00014	0.000829	CcSEcCtD
Valproic Acid—Immune system disorder—Doxorubicin—bone cancer	0.00014	0.000828	CcSEcCtD
Valproic Acid—Vertigo—Methotrexate—bone cancer	0.00014	0.000828	CcSEcCtD
Valproic Acid—Mediastinal disorder—Doxorubicin—bone cancer	0.00014	0.000826	CcSEcCtD
Valproic Acid—Leukopenia—Methotrexate—bone cancer	0.000139	0.000825	CcSEcCtD
Valproic Acid—Chills—Doxorubicin—bone cancer	0.000139	0.000823	CcSEcCtD
Valproic Acid—Arrhythmia—Doxorubicin—bone cancer	0.000138	0.000819	CcSEcCtD
Valproic Acid—Nausea—Cisplatin—bone cancer	0.000138	0.000814	CcSEcCtD
Valproic Acid—Vision blurred—Epirubicin—bone cancer	0.000137	0.000813	CcSEcCtD
Valproic Acid—Alopecia—Doxorubicin—bone cancer	0.000137	0.00081	CcSEcCtD
Valproic Acid—Cough—Methotrexate—bone cancer	0.000136	0.000804	CcSEcCtD
Valproic Acid—Mental disorder—Doxorubicin—bone cancer	0.000136	0.000803	CcSEcCtD
Valproic Acid—Ill-defined disorder—Epirubicin—bone cancer	0.000135	0.0008	CcSEcCtD
Valproic Acid—Malnutrition—Doxorubicin—bone cancer	0.000135	0.000798	CcSEcCtD
Valproic Acid—Anaemia—Epirubicin—bone cancer	0.000135	0.000797	CcSEcCtD
Valproic Acid—Agitation—Epirubicin—bone cancer	0.000134	0.000793	CcSEcCtD
Valproic Acid—Flatulence—Doxorubicin—bone cancer	0.000133	0.000787	CcSEcCtD
Valproic Acid—Chest pain—Methotrexate—bone cancer	0.000133	0.000785	CcSEcCtD
Valproic Acid—Arthralgia—Methotrexate—bone cancer	0.000133	0.000785	CcSEcCtD
Valproic Acid—Myalgia—Methotrexate—bone cancer	0.000133	0.000785	CcSEcCtD
Valproic Acid—Tension—Doxorubicin—bone cancer	0.000132	0.000783	CcSEcCtD
Valproic Acid—Dysgeusia—Doxorubicin—bone cancer	0.000132	0.000782	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000132	0.000779	CcSEcCtD
Valproic Acid—Malaise—Epirubicin—bone cancer	0.000131	0.000778	CcSEcCtD
Valproic Acid—Discomfort—Methotrexate—bone cancer	0.000131	0.000775	CcSEcCtD
Valproic Acid—Nervousness—Doxorubicin—bone cancer	0.000131	0.000775	CcSEcCtD
Valproic Acid—Vertigo—Epirubicin—bone cancer	0.000131	0.000775	CcSEcCtD
Valproic Acid—Leukopenia—Epirubicin—bone cancer	0.000131	0.000772	CcSEcCtD
Valproic Acid—Back pain—Doxorubicin—bone cancer	0.00013	0.000772	CcSEcCtD
Valproic Acid—Muscle spasms—Doxorubicin—bone cancer	0.00013	0.000767	CcSEcCtD
Valproic Acid—Palpitations—Epirubicin—bone cancer	0.000129	0.000762	CcSEcCtD
Valproic Acid—Confusional state—Methotrexate—bone cancer	0.000128	0.000759	CcSEcCtD
Valproic Acid—Cough—Epirubicin—bone cancer	0.000127	0.000753	CcSEcCtD
Valproic Acid—Anaphylactic shock—Methotrexate—bone cancer	0.000127	0.000752	CcSEcCtD
Valproic Acid—Vision blurred—Doxorubicin—bone cancer	0.000127	0.000752	CcSEcCtD
Valproic Acid—Infection—Methotrexate—bone cancer	0.000126	0.000747	CcSEcCtD
Valproic Acid—Hypertension—Epirubicin—bone cancer	0.000126	0.000745	CcSEcCtD
Valproic Acid—Ill-defined disorder—Doxorubicin—bone cancer	0.000125	0.000741	CcSEcCtD
Valproic Acid—Nervous system disorder—Methotrexate—bone cancer	0.000125	0.000738	CcSEcCtD
Valproic Acid—Anaemia—Doxorubicin—bone cancer	0.000125	0.000738	CcSEcCtD
Valproic Acid—Thrombocytopenia—Methotrexate—bone cancer	0.000125	0.000737	CcSEcCtD
Valproic Acid—Arthralgia—Epirubicin—bone cancer	0.000124	0.000734	CcSEcCtD
Valproic Acid—Chest pain—Epirubicin—bone cancer	0.000124	0.000734	CcSEcCtD
Valproic Acid—Myalgia—Epirubicin—bone cancer	0.000124	0.000734	CcSEcCtD
Valproic Acid—Agitation—Doxorubicin—bone cancer	0.000124	0.000734	CcSEcCtD
Valproic Acid—Anxiety—Epirubicin—bone cancer	0.000124	0.000732	CcSEcCtD
Valproic Acid—Skin disorder—Methotrexate—bone cancer	0.000124	0.000731	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000123	0.000729	CcSEcCtD
Valproic Acid—Hyperhidrosis—Methotrexate—bone cancer	0.000123	0.000727	CcSEcCtD
Valproic Acid—Discomfort—Epirubicin—bone cancer	0.000123	0.000726	CcSEcCtD
Valproic Acid—Malaise—Doxorubicin—bone cancer	0.000122	0.00072	CcSEcCtD
Valproic Acid—Dry mouth—Epirubicin—bone cancer	0.000121	0.000718	CcSEcCtD
Valproic Acid—Vertigo—Doxorubicin—bone cancer	0.000121	0.000717	CcSEcCtD
Valproic Acid—Anorexia—Methotrexate—bone cancer	0.000121	0.000717	CcSEcCtD
Valproic Acid—Leukopenia—Doxorubicin—bone cancer	0.000121	0.000715	CcSEcCtD
Valproic Acid—Confusional state—Epirubicin—bone cancer	0.00012	0.00071	CcSEcCtD
Valproic Acid—Palpitations—Doxorubicin—bone cancer	0.000119	0.000705	CcSEcCtD
Valproic Acid—Oedema—Epirubicin—bone cancer	0.000119	0.000704	CcSEcCtD
Valproic Acid—Anaphylactic shock—Epirubicin—bone cancer	0.000119	0.000704	CcSEcCtD
Valproic Acid—Hypotension—Methotrexate—bone cancer	0.000119	0.000703	CcSEcCtD
Valproic Acid—Infection—Epirubicin—bone cancer	0.000118	0.000699	CcSEcCtD
Valproic Acid—Cough—Doxorubicin—bone cancer	0.000118	0.000697	CcSEcCtD
Valproic Acid—Nervous system disorder—Epirubicin—bone cancer	0.000117	0.00069	CcSEcCtD
Valproic Acid—Thrombocytopenia—Epirubicin—bone cancer	0.000117	0.000689	CcSEcCtD
Valproic Acid—Hypertension—Doxorubicin—bone cancer	0.000116	0.000689	CcSEcCtD
Valproic Acid—Tachycardia—Epirubicin—bone cancer	0.000116	0.000687	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000116	0.000685	CcSEcCtD
Valproic Acid—Skin disorder—Epirubicin—bone cancer	0.000116	0.000684	CcSEcCtD
Valproic Acid—Hyperhidrosis—Epirubicin—bone cancer	0.000115	0.000681	CcSEcCtD
Valproic Acid—Insomnia—Methotrexate—bone cancer	0.000115	0.00068	CcSEcCtD
Valproic Acid—Arthralgia—Doxorubicin—bone cancer	0.000115	0.00068	CcSEcCtD
Valproic Acid—Chest pain—Doxorubicin—bone cancer	0.000115	0.00068	CcSEcCtD
Valproic Acid—Myalgia—Doxorubicin—bone cancer	0.000115	0.00068	CcSEcCtD
Valproic Acid—Anxiety—Doxorubicin—bone cancer	0.000114	0.000677	CcSEcCtD
Valproic Acid—Paraesthesia—Methotrexate—bone cancer	0.000114	0.000676	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000114	0.000675	CcSEcCtD
Valproic Acid—Discomfort—Doxorubicin—bone cancer	0.000113	0.000671	CcSEcCtD
Valproic Acid—Anorexia—Epirubicin—bone cancer	0.000113	0.000671	CcSEcCtD
Valproic Acid—Dyspnoea—Methotrexate—bone cancer	0.000113	0.000671	CcSEcCtD
Valproic Acid—Somnolence—Methotrexate—bone cancer	0.000113	0.000669	CcSEcCtD
Valproic Acid—Dry mouth—Doxorubicin—bone cancer	0.000112	0.000665	CcSEcCtD
Valproic Acid—Dyspepsia—Methotrexate—bone cancer	0.000112	0.000662	CcSEcCtD
Valproic Acid—Hypotension—Epirubicin—bone cancer	0.000111	0.000658	CcSEcCtD
Valproic Acid—Confusional state—Doxorubicin—bone cancer	0.000111	0.000657	CcSEcCtD
Valproic Acid—Decreased appetite—Methotrexate—bone cancer	0.000111	0.000654	CcSEcCtD
Valproic Acid—Anaphylactic shock—Doxorubicin—bone cancer	0.00011	0.000651	CcSEcCtD
Valproic Acid—Oedema—Doxorubicin—bone cancer	0.00011	0.000651	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Methotrexate—bone cancer	0.00011	0.00065	CcSEcCtD
Valproic Acid—Fatigue—Methotrexate—bone cancer	0.00011	0.000649	CcSEcCtD
Valproic Acid—Infection—Doxorubicin—bone cancer	0.000109	0.000647	CcSEcCtD
Valproic Acid—Pain—Methotrexate—bone cancer	0.000109	0.000643	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000108	0.000641	CcSEcCtD
Valproic Acid—Nervous system disorder—Doxorubicin—bone cancer	0.000108	0.000639	CcSEcCtD
Valproic Acid—Thrombocytopenia—Doxorubicin—bone cancer	0.000108	0.000638	CcSEcCtD
Valproic Acid—Insomnia—Epirubicin—bone cancer	0.000108	0.000637	CcSEcCtD
Valproic Acid—Tachycardia—Doxorubicin—bone cancer	0.000107	0.000636	CcSEcCtD
Valproic Acid—Skin disorder—Doxorubicin—bone cancer	0.000107	0.000633	CcSEcCtD
Valproic Acid—Paraesthesia—Epirubicin—bone cancer	0.000107	0.000632	CcSEcCtD
Valproic Acid—Hyperhidrosis—Doxorubicin—bone cancer	0.000106	0.00063	CcSEcCtD
Valproic Acid—Dyspnoea—Epirubicin—bone cancer	0.000106	0.000628	CcSEcCtD
Valproic Acid—Somnolence—Epirubicin—bone cancer	0.000106	0.000626	CcSEcCtD
Valproic Acid—Anorexia—Doxorubicin—bone cancer	0.000105	0.000621	CcSEcCtD
Valproic Acid—Feeling abnormal—Methotrexate—bone cancer	0.000105	0.00062	CcSEcCtD
Valproic Acid—Dyspepsia—Epirubicin—bone cancer	0.000105	0.00062	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Methotrexate—bone cancer	0.000104	0.000615	CcSEcCtD
Valproic Acid—Decreased appetite—Epirubicin—bone cancer	0.000103	0.000612	CcSEcCtD
Valproic Acid—Hypotension—Doxorubicin—bone cancer	0.000103	0.000609	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Epirubicin—bone cancer	0.000103	0.000608	CcSEcCtD
Valproic Acid—Fatigue—Epirubicin—bone cancer	0.000103	0.000607	CcSEcCtD
Valproic Acid—Pain—Epirubicin—bone cancer	0.000102	0.000602	CcSEcCtD
Valproic Acid—Constipation—Epirubicin—bone cancer	0.000102	0.000602	CcSEcCtD
Valproic Acid—Urticaria—Methotrexate—bone cancer	0.000101	0.000598	CcSEcCtD
Valproic Acid—Body temperature increased—Methotrexate—bone cancer	0.000101	0.000595	CcSEcCtD
Valproic Acid—Abdominal pain—Methotrexate—bone cancer	0.000101	0.000595	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.0001	0.000594	CcSEcCtD
Valproic Acid—Insomnia—Doxorubicin—bone cancer	9.96e-05	0.000589	CcSEcCtD
Valproic Acid—Paraesthesia—Doxorubicin—bone cancer	9.89e-05	0.000585	CcSEcCtD
Valproic Acid—Dyspnoea—Doxorubicin—bone cancer	9.82e-05	0.000581	CcSEcCtD
Valproic Acid—Feeling abnormal—Epirubicin—bone cancer	9.81e-05	0.00058	CcSEcCtD
Valproic Acid—Somnolence—Doxorubicin—bone cancer	9.79e-05	0.000579	CcSEcCtD
Valproic Acid—HDAC2—Chromatin modifying enzymes—CDK4—bone cancer	9.74e-05	0.000765	CbGpPWpGaD
Valproic Acid—Gastrointestinal pain—Epirubicin—bone cancer	9.73e-05	0.000576	CcSEcCtD
Valproic Acid—Dyspepsia—Doxorubicin—bone cancer	9.69e-05	0.000573	CcSEcCtD
Valproic Acid—HDAC2—Hemostasis—SPARC—bone cancer	9.62e-05	0.000756	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—GNA11—bone cancer	9.62e-05	0.000756	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—NT5C3A—bone cancer	9.58e-05	0.000752	CbGpPWpGaD
Valproic Acid—Decreased appetite—Doxorubicin—bone cancer	9.57e-05	0.000566	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Doxorubicin—bone cancer	9.51e-05	0.000562	CcSEcCtD
Valproic Acid—Fatigue—Doxorubicin—bone cancer	9.49e-05	0.000562	CcSEcCtD
Valproic Acid—Urticaria—Epirubicin—bone cancer	9.45e-05	0.000559	CcSEcCtD
Valproic Acid—Constipation—Doxorubicin—bone cancer	9.42e-05	0.000557	CcSEcCtD
Valproic Acid—Pain—Doxorubicin—bone cancer	9.42e-05	0.000557	CcSEcCtD
Valproic Acid—Abdominal pain—Epirubicin—bone cancer	9.41e-05	0.000557	CcSEcCtD
Valproic Acid—Body temperature increased—Epirubicin—bone cancer	9.41e-05	0.000557	CcSEcCtD
Valproic Acid—Hypersensitivity—Methotrexate—bone cancer	9.37e-05	0.000554	CcSEcCtD
Valproic Acid—PTGS1—Biological oxidations—GSTP1—bone cancer	9.29e-05	0.00073	CbGpPWpGaD
Valproic Acid—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	9.19e-05	0.000722	CbGpPWpGaD
Valproic Acid—Asthenia—Methotrexate—bone cancer	9.12e-05	0.00054	CcSEcCtD
Valproic Acid—Feeling abnormal—Doxorubicin—bone cancer	9.07e-05	0.000537	CcSEcCtD
Valproic Acid—HDAC2—Glucocorticoid receptor regulatory network—TP53—bone cancer	9.02e-05	0.000709	CbGpPWpGaD
Valproic Acid—Gastrointestinal pain—Doxorubicin—bone cancer	9e-05	0.000533	CcSEcCtD
Valproic Acid—Pruritus—Methotrexate—bone cancer	9e-05	0.000532	CcSEcCtD
Valproic Acid—UGT1A8—Metabolism—ENO2—bone cancer	8.96e-05	0.000704	CbGpPWpGaD
Valproic Acid—HDAC2—Direct p53 effectors—JUN—bone cancer	8.91e-05	0.0007	CbGpPWpGaD
Valproic Acid—SLC22A6—Transmembrane transport of small molecules—TUBB2A—bone cancer	8.88e-05	0.000698	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—GNA11—bone cancer	8.8e-05	0.000691	CbGpPWpGaD
Valproic Acid—CYP2A6—Biological oxidations—GSTP1—bone cancer	8.79e-05	0.00069	CbGpPWpGaD
Valproic Acid—Hypersensitivity—Epirubicin—bone cancer	8.77e-05	0.000519	CcSEcCtD
Valproic Acid—Urticaria—Doxorubicin—bone cancer	8.75e-05	0.000518	CcSEcCtD
Valproic Acid—SLC16A1—Hemostasis—IL3—bone cancer	8.72e-05	0.000685	CbGpPWpGaD
Valproic Acid—Abdominal pain—Doxorubicin—bone cancer	8.7e-05	0.000515	CcSEcCtD
Valproic Acid—Body temperature increased—Doxorubicin—bone cancer	8.7e-05	0.000515	CcSEcCtD
Valproic Acid—Diarrhoea—Methotrexate—bone cancer	8.7e-05	0.000515	CcSEcCtD
Valproic Acid—Asthenia—Epirubicin—bone cancer	8.54e-05	0.000505	CcSEcCtD
Valproic Acid—Pruritus—Epirubicin—bone cancer	8.42e-05	0.000498	CcSEcCtD
Valproic Acid—Dizziness—Methotrexate—bone cancer	8.41e-05	0.000498	CcSEcCtD
Valproic Acid—CYP2C18—Metabolism—NT5C3A—bone cancer	8.37e-05	0.000658	CbGpPWpGaD
Valproic Acid—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	8.35e-05	0.000656	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—DHFR—bone cancer	8.31e-05	0.000653	CbGpPWpGaD
Valproic Acid—CYP2B6—Biological oxidations—CYP3A4—bone cancer	8.29e-05	0.000651	CbGpPWpGaD
Valproic Acid—PTGS1—Selenium Micronutrient Network—PTGS2—bone cancer	8.23e-05	0.000646	CbGpPWpGaD
Valproic Acid—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	8.17e-05	0.000642	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—NT5C3A—bone cancer	8.15e-05	0.00064	CbGpPWpGaD
Valproic Acid—Diarrhoea—Epirubicin—bone cancer	8.14e-05	0.000482	CcSEcCtD
Valproic Acid—Hypersensitivity—Doxorubicin—bone cancer	8.11e-05	0.00048	CcSEcCtD
Valproic Acid—CYP3A5—Biological oxidations—CYP3A4—bone cancer	8.1e-05	0.000636	CbGpPWpGaD
Valproic Acid—Vomiting—Methotrexate—bone cancer	8.08e-05	0.000478	CcSEcCtD
Valproic Acid—Rash—Methotrexate—bone cancer	8.02e-05	0.000474	CcSEcCtD
Valproic Acid—Dermatitis—Methotrexate—bone cancer	8.01e-05	0.000474	CcSEcCtD
Valproic Acid—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	7.99e-05	0.000628	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—NDUFA12—bone cancer	7.99e-05	0.000627	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—IL3—bone cancer	7.98e-05	0.000627	CbGpPWpGaD
Valproic Acid—Headache—Methotrexate—bone cancer	7.97e-05	0.000471	CcSEcCtD
Valproic Acid—Asthenia—Doxorubicin—bone cancer	7.9e-05	0.000467	CcSEcCtD
Valproic Acid—Dizziness—Epirubicin—bone cancer	7.87e-05	0.000466	CcSEcCtD
Valproic Acid—UGT2B15—Metabolism—ENO2—bone cancer	7.83e-05	0.000615	CbGpPWpGaD
Valproic Acid—Pruritus—Doxorubicin—bone cancer	7.79e-05	0.000461	CcSEcCtD
Valproic Acid—UGT1A8—Metabolism—GNA11—bone cancer	7.77e-05	0.00061	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—TGFBR2—bone cancer	7.62e-05	0.000598	CbGpPWpGaD
Valproic Acid—HDAC2—Cell Cycle—TP53—bone cancer	7.58e-05	0.000595	CbGpPWpGaD
Valproic Acid—Vomiting—Epirubicin—bone cancer	7.57e-05	0.000448	CcSEcCtD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	7.56e-05	0.000593	CbGpPWpGaD
Valproic Acid—Nausea—Methotrexate—bone cancer	7.55e-05	0.000447	CcSEcCtD
Valproic Acid—Diarrhoea—Doxorubicin—bone cancer	7.53e-05	0.000446	CcSEcCtD
Valproic Acid—HDAC9—Signaling Pathways—SMO—bone cancer	7.52e-05	0.000591	CbGpPWpGaD
Valproic Acid—Rash—Epirubicin—bone cancer	7.5e-05	0.000444	CcSEcCtD
Valproic Acid—Dermatitis—Epirubicin—bone cancer	7.5e-05	0.000444	CcSEcCtD
Valproic Acid—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	7.46e-05	0.000586	CbGpPWpGaD
Valproic Acid—Headache—Epirubicin—bone cancer	7.45e-05	0.000441	CcSEcCtD
Valproic Acid—HDAC2—Signaling by NGF—KIT—bone cancer	7.35e-05	0.000577	CbGpPWpGaD
Valproic Acid—Dizziness—Doxorubicin—bone cancer	7.28e-05	0.000431	CcSEcCtD
Valproic Acid—UGT2B15—Metabolism—DHFR—bone cancer	7.27e-05	0.000571	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NOTCH—TP53—bone cancer	7.18e-05	0.000564	CbGpPWpGaD
Valproic Acid—CYP1A2—Phase II conjugation—GSTP1—bone cancer	7.13e-05	0.00056	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—NR1I2—bone cancer	7.12e-05	0.000559	CbGpPWpGaD
Valproic Acid—CYP2B6—Biological oxidations—GSTP1—bone cancer	7.09e-05	0.000557	CbGpPWpGaD
Valproic Acid—Nausea—Epirubicin—bone cancer	7.07e-05	0.000418	CcSEcCtD
Valproic Acid—UGT1A8—Metabolism—CYP3A4—bone cancer	7.04e-05	0.000553	CbGpPWpGaD
Valproic Acid—CYP2C8—Biological oxidations—CYP3A4—bone cancer	7.02e-05	0.000551	CbGpPWpGaD
Valproic Acid—HDAC2—Direct p53 effectors—EGFR—bone cancer	7e-05	0.00055	CbGpPWpGaD
Valproic Acid—Vomiting—Doxorubicin—bone cancer	7e-05	0.000414	CcSEcCtD
Valproic Acid—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	6.99e-05	0.000549	CbGpPWpGaD
Valproic Acid—Rash—Doxorubicin—bone cancer	6.94e-05	0.000411	CcSEcCtD
Valproic Acid—Dermatitis—Doxorubicin—bone cancer	6.94e-05	0.00041	CcSEcCtD
Valproic Acid—CYP3A5—Biological oxidations—GSTP1—bone cancer	6.93e-05	0.000544	CbGpPWpGaD
Valproic Acid—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	6.92e-05	0.000544	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—BRAF—bone cancer	6.91e-05	0.000543	CbGpPWpGaD
Valproic Acid—Headache—Doxorubicin—bone cancer	6.9e-05	0.000408	CcSEcCtD
Valproic Acid—HDAC9—Signaling Pathways—GNA11—bone cancer	6.88e-05	0.00054	CbGpPWpGaD
Valproic Acid—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	6.83e-05	0.000537	CbGpPWpGaD
Valproic Acid—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	6.8e-05	0.000534	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—GNA11—bone cancer	6.79e-05	0.000533	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—JUN—bone cancer	6.67e-05	0.000524	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—NT5C3A—bone cancer	6.62e-05	0.00052	CbGpPWpGaD
Valproic Acid—Nausea—Doxorubicin—bone cancer	6.54e-05	0.000387	CcSEcCtD
Valproic Acid—UGT1A6—Metabolism—ENO2—bone cancer	6.54e-05	0.000514	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—NDUFA12—bone cancer	6.51e-05	0.000511	CbGpPWpGaD
Valproic Acid—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	6.44e-05	0.000506	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—ATF1—bone cancer	6.4e-05	0.000502	CbGpPWpGaD
Valproic Acid—CYP2C19—Biological oxidations—CYP3A4—bone cancer	6.26e-05	0.000492	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—IL3—bone cancer	6.24e-05	0.00049	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	6.21e-05	0.000488	CbGpPWpGaD
Valproic Acid—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	6.18e-05	0.000485	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—NDUFA12—bone cancer	6.16e-05	0.000484	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—CYP3A4—bone cancer	6.16e-05	0.000484	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—DHFR—bone cancer	6.07e-05	0.000476	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—GSTP1—bone cancer	6.02e-05	0.000473	CbGpPWpGaD
Valproic Acid—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—bone cancer	6.02e-05	0.000473	CbGpPWpGaD
Valproic Acid—CYP2C8—Biological oxidations—GSTP1—bone cancer	6e-05	0.000471	CbGpPWpGaD
Valproic Acid—ACADSB—Metabolism—PTGS2—bone cancer	5.94e-05	0.000467	CbGpPWpGaD
Valproic Acid—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	5.92e-05	0.000465	CbGpPWpGaD
Valproic Acid—HDAC2—Direct p53 effectors—TP53—bone cancer	5.88e-05	0.000462	CbGpPWpGaD
Valproic Acid—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	5.81e-05	0.000456	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—MDM2—bone cancer	5.79e-05	0.000455	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—PLAU—bone cancer	5.72e-05	0.000449	CbGpPWpGaD
Valproic Acid—CYP2C9—Biological oxidations—CYP3A4—bone cancer	5.71e-05	0.000449	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—GNA11—bone cancer	5.67e-05	0.000445	CbGpPWpGaD
Valproic Acid—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	5.63e-05	0.000442	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	5.6e-05	0.00044	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—NT5C3A—bone cancer	5.4e-05	0.000424	CbGpPWpGaD
Valproic Acid—CYP2C19—Biological oxidations—GSTP1—bone cancer	5.36e-05	0.000421	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—RGS1—bone cancer	5.34e-05	0.000419	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—GRM4—bone cancer	5.34e-05	0.000419	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TGFBR2—bone cancer	5.33e-05	0.000419	CbGpPWpGaD
Valproic Acid—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	5.28e-05	0.000415	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—GSTP1—bone cancer	5.27e-05	0.000414	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—EIF2S1—bone cancer	5.26e-05	0.000413	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—PLAU—bone cancer	5.23e-05	0.000411	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—KIT—bone cancer	5.2e-05	0.000408	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—CYP3A4—bone cancer	5.14e-05	0.000404	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—NT5C3A—bone cancer	5.1e-05	0.000401	CbGpPWpGaD
Valproic Acid—OGDH—Metabolism—PTGS2—bone cancer	5.05e-05	0.000397	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—ENO2—bone cancer	5.05e-05	0.000396	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—IGF1R—bone cancer	5.02e-05	0.000394	CbGpPWpGaD
Valproic Acid—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	4.97e-05	0.000391	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—NDUFA12—bone cancer	4.97e-05	0.00039	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—ENO2—bone cancer	4.91e-05	0.000386	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—BRAF—bone cancer	4.89e-05	0.000384	CbGpPWpGaD
Valproic Acid—CYP2C9—Biological oxidations—GSTP1—bone cancer	4.88e-05	0.000384	CbGpPWpGaD
Valproic Acid—CYP1A2—Biological oxidations—CYP3A4—bone cancer	4.88e-05	0.000383	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—NDUFA12—bone cancer	4.86e-05	0.000381	CbGpPWpGaD
Valproic Acid—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	4.82e-05	0.000378	CbGpPWpGaD
Valproic Acid—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	4.81e-05	0.000378	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—DHFR—bone cancer	4.68e-05	0.000368	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—GRM1—bone cancer	4.63e-05	0.000364	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—EZH2—bone cancer	4.57e-05	0.000359	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—DHFR—bone cancer	4.56e-05	0.000358	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—ENO2—bone cancer	4.5e-05	0.000353	CbGpPWpGaD
Valproic Acid—HDAC2—Circadian rythm related genes—TP53—bone cancer	4.4e-05	0.000346	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	4.4e-05	0.000346	CbGpPWpGaD
Valproic Acid—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	4.4e-05	0.000346	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—GSTP1—bone cancer	4.4e-05	0.000345	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—GNA11—bone cancer	4.38e-05	0.000344	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—NDUFA12—bone cancer	4.21e-05	0.00033	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—ENO2—bone cancer	4.2e-05	0.00033	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—DHFR—bone cancer	4.17e-05	0.000328	CbGpPWpGaD
Valproic Acid—CYP1A2—Biological oxidations—GSTP1—bone cancer	4.17e-05	0.000328	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—NT5C3A—bone cancer	4.12e-05	0.000323	CbGpPWpGaD
Valproic Acid—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	4.12e-05	0.000323	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—MDM2—bone cancer	4.09e-05	0.000322	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—NT5C3A—bone cancer	4.02e-05	0.000316	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—CYP3A4—bone cancer	3.97e-05	0.000312	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling by NGF—EGFR—bone cancer	3.96e-05	0.000311	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—PTGS2—bone cancer	3.95e-05	0.00031	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—GNA11—bone cancer	3.9e-05	0.000306	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—DHFR—bone cancer	3.89e-05	0.000306	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—NDUFA12—bone cancer	3.75e-05	0.000295	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—ENO2—bone cancer	3.67e-05	0.000288	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—KIT—bone cancer	3.64e-05	0.000286	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—GNA11—bone cancer	3.64e-05	0.000286	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—ENO2—bone cancer	3.57e-05	0.00028	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—CYP3A4—bone cancer	3.54e-05	0.000278	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—NT5C3A—bone cancer	3.49e-05	0.000274	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—NDUFA12—bone cancer	3.42e-05	0.000269	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—BRAF—bone cancer	3.42e-05	0.000269	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—DHFR—bone cancer	3.4e-05	0.000267	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—GSTP1—bone cancer	3.39e-05	0.000267	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—DHFR—bone cancer	3.31e-05	0.00026	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—TGFBR2—bone cancer	3.3e-05	0.000259	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—CYP3A4—bone cancer	3.3e-05	0.000259	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—SMO—bone cancer	3.26e-05	0.000256	CbGpPWpGaD
Valproic Acid—CYP3A4—Biological oxidations—GSTP1—bone cancer	3.22e-05	0.000253	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—GNA11—bone cancer	3.18e-05	0.00025	CbGpPWpGaD
Valproic Acid—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	3.18e-05	0.00025	CbGpPWpGaD
Valproic Acid—UGT1A8—Metabolism—PTGS2—bone cancer	3.12e-05	0.000245	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—NT5C3A—bone cancer	3.11e-05	0.000244	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—GNA11—bone cancer	3.09e-05	0.000243	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—GSTP1—bone cancer	3.02e-05	0.000238	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—GNA11—bone cancer	2.98e-05	0.000234	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—NDUFA12—bone cancer	2.93e-05	0.00023	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—ENO2—bone cancer	2.9e-05	0.000228	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—CYP3A4—bone cancer	2.88e-05	0.000226	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—MDM2—bone cancer	2.87e-05	0.000225	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—NT5C3A—bone cancer	2.84e-05	0.000223	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—GSTP1—bone cancer	2.82e-05	0.000222	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—CYP3A4—bone cancer	2.8e-05	0.00022	CbGpPWpGaD
Valproic Acid—HDAC9—Disease—EGFR—bone cancer	2.8e-05	0.00022	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—ATF1—bone cancer	2.77e-05	0.000218	CbGpPWpGaD
Valproic Acid—UGT2B15—Metabolism—PTGS2—bone cancer	2.73e-05	0.000214	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL3—bone cancer	2.7e-05	0.000212	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—DHFR—bone cancer	2.69e-05	0.000211	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—GNA11—bone cancer	2.51e-05	0.000197	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—JUN—bone cancer	2.49e-05	0.000196	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—GSTP1—bone cancer	2.47e-05	0.000194	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—MMP9—bone cancer	2.42e-05	0.00019	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—NT5C3A—bone cancer	2.42e-05	0.00019	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—GSTP1—bone cancer	2.4e-05	0.000188	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—ENO2—bone cancer	2.36e-05	0.000186	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TGFBR2—bone cancer	2.31e-05	0.000182	CbGpPWpGaD
Valproic Acid—SLC16A1—Hemostasis—TP53—bone cancer	2.3e-05	0.000181	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—CYP3A4—bone cancer	2.28e-05	0.000179	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—PTGS2—bone cancer	2.28e-05	0.000179	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.27e-05	0.000178	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—NDUFA12—bone cancer	2.26e-05	0.000177	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—KIT—bone cancer	2.25e-05	0.000177	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ENO2—bone cancer	2.23e-05	0.000176	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—DHFR—bone cancer	2.19e-05	0.000172	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IGF1R—bone cancer	2.18e-05	0.000171	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—BRAF—bone cancer	2.12e-05	0.000166	CbGpPWpGaD
Valproic Acid—HDAC2—Hemostasis—TP53—bone cancer	2.1e-05	0.000165	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—DHFR—bone cancer	2.07e-05	0.000163	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—GNA11—bone cancer	2.05e-05	0.000161	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—EGFR—bone cancer	1.96e-05	0.000154	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—GSTP1—bone cancer	1.95e-05	0.000153	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—GNA11—bone cancer	1.94e-05	0.000152	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—NT5C3A—bone cancer	1.87e-05	0.000147	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CYP3A4—bone cancer	1.86e-05	0.000146	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.85e-05	0.000145	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ENO2—bone cancer	1.8e-05	0.000142	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MDM2—bone cancer	1.78e-05	0.000139	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ENO2—bone cancer	1.76e-05	0.000138	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—PTGS2—bone cancer	1.76e-05	0.000138	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CYP3A4—bone cancer	1.76e-05	0.000138	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—PTGS2—bone cancer	1.71e-05	0.000134	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—DHFR—bone cancer	1.67e-05	0.000131	CbGpPWpGaD
Valproic Acid—HDAC9—Signaling Pathways—TP53—bone cancer	1.64e-05	0.000129	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—DHFR—bone cancer	1.64e-05	0.000128	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—GSTP1—bone cancer	1.59e-05	0.000125	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—KIT—bone cancer	1.58e-05	0.000124	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—PTGS2—bone cancer	1.57e-05	0.000123	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GNA11—bone cancer	1.56e-05	0.000123	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GNA11—bone cancer	1.53e-05	0.00012	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ENO2—bone cancer	1.53e-05	0.00012	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—GSTP1—bone cancer	1.5e-05	0.000118	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—BRAF—bone cancer	1.48e-05	0.000117	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—PTGS2—bone cancer	1.46e-05	0.000115	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CYP3A4—bone cancer	1.42e-05	0.000111	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—DHFR—bone cancer	1.42e-05	0.000111	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CYP3A4—bone cancer	1.39e-05	0.000109	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ENO2—bone cancer	1.36e-05	0.000107	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GNA11—bone cancer	1.32e-05	0.000104	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PTGS2—bone cancer	1.28e-05	0.0001	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—DHFR—bone cancer	1.26e-05	9.93e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MDM2—bone cancer	1.24e-05	9.76e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PTGS2—bone cancer	1.24e-05	9.76e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ENO2—bone cancer	1.24e-05	9.76e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—EGFR—bone cancer	1.21e-05	9.53e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GSTP1—bone cancer	1.21e-05	9.52e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CYP3A4—bone cancer	1.2e-05	9.43e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.19e-05	9.38e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GSTP1—bone cancer	1.18e-05	9.31e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GNA11—bone cancer	1.18e-05	9.28e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—DHFR—bone cancer	1.15e-05	9.05e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—JUN—bone cancer	1.08e-05	8.49e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GNA11—bone cancer	1.08e-05	8.46e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CYP3A4—bone cancer	1.07e-05	8.41e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.07e-05	8.37e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ENO2—bone cancer	1.06e-05	8.34e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MMP9—bone cancer	1.05e-05	8.26e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GSTP1—bone cancer	1.03e-05	8.06e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PTGS2—bone cancer	1.01e-05	7.93e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—DHFR—bone cancer	9.85e-06	7.74e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CYP3A4—bone cancer	9.77e-06	7.67e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	9.72e-06	7.63e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GNA11—bone cancer	9.21e-06	7.23e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GSTP1—bone cancer	9.16e-06	7.2e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—EGFR—bone cancer	8.49e-06	6.67e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GSTP1—bone cancer	8.35e-06	6.56e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CYP3A4—bone cancer	8.35e-06	6.56e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	8.3e-06	6.52e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PTGS2—bone cancer	8.23e-06	6.47e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ENO2—bone cancer	8.19e-06	6.44e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PTGS2—bone cancer	7.78e-06	6.11e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—DHFR—bone cancer	7.6e-06	5.97e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GSTP1—bone cancer	7.14e-06	5.61e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TP53—bone cancer	7.13e-06	5.6e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GNA11—bone cancer	7.1e-06	5.58e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PTGS2—bone cancer	6.28e-06	4.93e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PTGS2—bone cancer	6.14e-06	4.82e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GSTP1—bone cancer	5.51e-06	4.33e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PTGS2—bone cancer	5.32e-06	4.18e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PTGS2—bone cancer	4.75e-06	3.73e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PTGS2—bone cancer	4.33e-06	3.4e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PTGS2—bone cancer	3.7e-06	2.9e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PTGS2—bone cancer	2.85e-06	2.24e-05	CbGpPWpGaD
